The relative levels of these adipokines are such that they adversely affect insulin sensitivity; adiponectin improves insulin signaling, while resistin blocks it, thus leading to insulin resistance and facilitating the progression from MASLD to T2DM (193). The gene discussed is RETN; the disease is type 2 diabetes mellitus.